Should the FDA reconsider antidepressant boxed warnings?
January 9, 2025

The University of Cincinnati's Jeffrey Strawn, MD, spoke with Medscape about whether the Food and Drug Administration should reevaluate boxed warnings on antidepressants linking the medications to an increased risk for suicidal thoughts and behaviors in young people.